Previous close | 11.67 |
Open | 11.70 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 11.67 - 11.67 |
52-week range | 11.54 - 23.60 |
Volume | |
Avg. volume | 401 |
Market cap | 7.924B |
Beta (5Y monthly) | 0.78 |
PE ratio (TTM) | 27.14 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.28 (2.38%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
M3 Wake Research, a leading fully integrated network of clinical research sites and one of North America's largest providers of Phase I-IV clinical trials, is expanding operations into Charleston, SC with the opening of a clinical research practice. Operating as Charleston Clinical Trials, LLC, the new center is led by Donald Hurley, DO, and located at 2270 Ashley Crossing Drive in Charleston.